Neurophth’s NR082 Gene Therapy Completes Phase III Enrollment
China-based gene therapy specialist Neurophth Biotechnology Ltd has announced the completion of all-patient enrollment and...
Company
Sinovac’s Hepatitis A Vaccine Healive Approved in Egypt
China-based Sinovac Biotech Ltd (NASDAQ: SVA) has announced obtaining market approval from the Egyptian Drug...
Asieris’ Uro-G Bladder Endoscope Catheter Awaits NMPA Approval
China-based urogenital cancer specialist Jiangsu Yahong Meditech Co., Ltd (Asieris, SHA: 688176) has announced that...
Merck KGaA Partners with Beijing for Drug Imports via Beijing Ports
Merck KGaA (ETR: MRK), a leading German pharmaceutical company, has struck a partnership with the...
Insilico Medicine’s COVID-19 Drug ISM3312 Enters Clinical Trials
China-based AI-powered drug discovery firm Insilico Medicine has announced that its ISM3312, an oral COVID-19...
Meihua International Partners with Hainan for Medical Tech Park and R&D Center
Meihua International Medical Technologies Co., Ltd (NASDAQ: MHUA), a specialist in Chinese medical consumables, has...
Kactus Biosystems and Levinthal Biotech Deepen Strategic Partnership
Kactus Biosystems, a Shanghai-based firm specializing in target proteins and raw enzymes, has announced a...
Junshi Biosciences’ PD-1 Inhibitor Tuoyi Shows Promise in Phase III TNBC Study
Junshi Biosciences Co., Ltd (HKG: 1877, SHA: 688180) has announced significant progress in the Phase...
Abbott Partners with Sinopharm for Expanded Medical Solutions in China
US-based Abbott (NYSE: ABT) has entered into a strategic partnership with Sinopharm’s China National Medical...
Luoxin’s Tegoprazan Gains NMPA Review for Duodenal Ulcer Treatment
Shandong Luoxin Pharmaceutical Group Stock Co., Ltd (SHE: 002793), a leading China-based pharmaceutical company, has...
Shanghai Pharmaceuticals’ X842 Accepted for NMPA Review for Reflux Esophagitis
China-based Shanghai Pharmaceuticals Holding Co., Ltd (SHA: 601607) has announced that the National Medical Products...
We-Linking Raises Tens of Millions in Angel Round for Brain-Computer Interface
We-Linking, a developer of fully implantable wireless brain-computer interface systems based in Shenzhen, has reportedly...
Hybio Pharma and CR Medicine Collaborate on Market Expansion
China-based Hybio Pharmaceutical Co., Ltd (SHE: 300199) has entered into a collaboration agreement with compatriot...
Junshi Biosciences Seeks UK MHRA Approval for PD-1 Inhibitor Tuoyi
Junshi Biosciences (HKG: 1877, SHA: 688180), a leading China-based biotech firm, has announced the submission...
Chinagene Tech Initiates ZVS101e Gene Therapy Trial for Bietti’s Crystalline Dystrophy
Beijing-based Chinagene Tech, a specialist in hereditary ophthalmopathy diagnosis and gene therapy, has announced the...
Ascletis Pharma’s ASC10 Shows Promising Phase I Results at CROI 2023
China-based Ascletis Pharma Inc. (HKG: 1672) has announced positive results from a Phase I clinical...
Beijing Huashen Shengdian Secures Angel Funding for Pelvic Surgery Monitor R&D
China-based intraoperative nerve monitoring technology developer Beijing Huashen Shengdian Medical Technology Co., Ltd has reportedly...
Zhaoke’s Generic Bimatoprost + Timolol Maleate Eye Drops Approved in China
Lee’s Pharmaceutical Holdings Ltd (HKG: 0950) former subsidiary Zhaoke Ophthalmology Ltd (HKG: 6622) has announced...
Sino Biopharmaceutical’s Limaprost Approved by NMPA for Lumbar Spinal Stenosis Treatment
Sino Biopharmaceutical Ltd (HKG: 1177) has announced that it has received marketing approval from China’s...
Biocytogen’s ‘Nano 100 Project’ Aims to Develop Over 100 Fully Human Nanobody Drugs
China-based Biocytogen Pharmaceuticals (Beijing) Co., Ltd has announced the launch of the “Nano 100 Project,”...